Condition

Edema

ClinicalTrials.gov condition label

Clinical trials25
Recruiting3
Common interventions25
Lead sponsors shown15

Clinical trials

25 shown
LymphBridge: Surgical Evaluation for Breast Cancer-Associated Lymphedema (BioBridge)NCT04606030 · 2020-10-26
RECRUITING
Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)NCT04278404 · 2020-03-05
RECRUITING
Screening For BCRL In Targeted Therapy For Breast CancerNCT05142800 · 2018-12-13
RECRUITING
Comparing Natriuretic Effects of ER Torsemide to IR Torsemide in Patients With Heart FailureNCT06995144 · 2025-05-01
WITHDRAWN
Effect of a Focused Point-of-care Ultrasonography Screening Protocol in Hospitalized PatientsNCT07656428 · 2025-04-05
ACTIVE_NOT_RECRUITING
Naturally Controlled Decongestion Using Renal Independent System in ADHF Patients, a European RegistryNCT06401109 · 2025-02-01
UNKNOWN
Efficacy and Safety of Combination Diuretic Therapy in Patients With Acute Decompensated Heart Failure and Volume OverloadNCT06414759 · 2024-07-01
UNKNOWN
Assess the Efficacy and Safety of Repeat Intravitreal Injections of Foselutoclax (UBX1325) in Patients With DME (ASPIRE)NCT06011798 · 2023-08-23
COMPLETED
AquaPass Device in Treatment of CHF PatientsNCT05843201 · 2022-02-20
COMPLETED
PVP-Guided Decongestive Therapy in HFNCT05217342 · 2022-01-01
UNKNOWN
GOREISAN for Heart Failure (GOREISAN-HF) TrialNCT04691700 · 2021-01-19
ACTIVE_NOT_RECRUITING
A Dual-center Study Evaluating Clinical Acceptance of a NPWT Wound Care SystemNCT04593693 · 2020-12-10
COMPLETED
Lymphatic Function in Patients With Secondary Tricuspid Valve RegurgitationNCT04595448 · 2020-09-15
COMPLETED
Effect of Vitrectomy on the Evolution of Refractory Diabetic Macular EdemaNCT03603990 · 2018-09-01
WITHDRAWN
The Mount Sinai Diabetic Foot Ulcer Prospective TrialNCT03404895 · 2018-04-13
WITHDRAWN
Kinesio Tex Tape in Reducing Edema and Seroma After Complex Reconstructive Breast SurgeryNCT03477565 · 2018-04-03
UNKNOWN
Effect of Body Weight Loading on Urinary Electrolyte ExcretionNCT03213717 · 2017-06-13
COMPLETED
Carboplatin and Paclitaxel With or Without Panitumumab in Treating Patients With Invasive Triple Negative Breast CancerNCT02876107 · 2016-10-06
ACTIVE_NOT_RECRUITING
Prospective Evaluation of a Surgical Solution for Breast Cancer-Associated LymphedemaNCT02734979 · 2016-07-20
COMPLETED
Breast Edema Compression VestNCT02627976 · 2016-02-01
COMPLETED
Pembrolizumab in Treating Patients With Stage IV Metastatic or Recurrent Inflammatory Breast Cancer or Triple-Negative Breast Cancer Who Have Achieved Clinical Response or Stable Disease to Prior ChemotherapyNCT02411656 · 2015-06-11
ACTIVE_NOT_RECRUITING
Mild Compression Sock for Control of Lower Extremity Edema in Individuals With DiabetesNCT01529385 · 2012-02-01
COMPLETED
Effect of Normatec Pump for Relief of Leg EdemaNCT01112150 · 2010-04-01
UNKNOWN
A Dose-finding Study of OPC-41061 in Treatment of Cardiac Edema (Congestive Heart Failure)NCT00234104 · 2004-08-01
COMPLETED
Trial Assessing the Effect of Preoperative Furosemide on Intraoperative Blood PressureNCT00115726 · 2000-09-01
COMPLETED

Common interventions

Laboratory Biomarker AnalysisOTHER2AcetazolamideDRUG1AfliberceptDRUG1AquaPassDEVICE1Biobridge and lymph node transferDEVICE1BioBridge® Collagen MatrixDEVICE1CarboplatinDRUG1Compression vest, ThuasneDEVICE1Conventional TherapyDEVICE1Diuretic therapyDRUG1Extended Release Torsemide TabletsDRUG1foselutoclaxDRUG1furosemideDRUG1GoreisanDRUG1Heavy Casall HIT weight vestOTHER1Immedate Release Torsemide TabletsDRUG1Invia Motion Endure NPWT systemDEVICE1IV Loop DiureticsDRUG1Kinesio tape lymphatic drainage technique applicationDEVICE1Light Casall HIT weight vestOTHER1MetolazoneDRUG1mild compression diabetic sockDEVICE1NormaTec PumpDEVICE1OPC-41061(Tolvaptan)DRUG1PaclitaxelDRUG1

Trial status mix

COMPLETED10
UNKNOWN5
ACTIVE_NOT_RECRUITING4
RECRUITING3
WITHDRAWN3

Phase mix

NA12
PHASE45
PHASE24

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.